Human Phenotype Ontology

Human Phenotype Ontology
Name	Human Phenotype Ontology
Type	Biomedical ontology
Domain	Genomic medicine, Clinical genetics
Established	2008

Human Phenotype Ontology

The Human Phenotype Ontology provides a standardized vocabulary for phenotypic abnormalities encountered in human disease, enabling integration across clinical genetics, genomic research, and computational biology. It connects clinical descriptions with resources used by institutions such as National Institutes of Health, Broad Institute, Wellcome Sanger Institute, Stanford University, and Massachusetts General Hospital, and supports projects involving organizations like Genomics England, European Bioinformatics Institute, American College of Medical Genetics and Genomics, World Health Organization, and European Union. The ontology underpins platforms used by initiatives including ClinVar, DECIPHER, ExAC, gnomAD, UK Biobank, 1000 Genomes Project, and The Cancer Genome Atlas.

Overview

The ontology serves as a structured vocabulary for phenotypic abnormalities observed in patients evaluated at centers such as Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Children's Hospital of Philadelphia, and Great Ormond Street Hospital. It links phenotype terms to genotype data generated by consortia like Human Genome Project, ENCODE Project, International HapMap Project, All of Us Research Program, and iPSCORE. Clinicians at institutions like Rady Children's Hospital, researchers at Cold Spring Harbor Laboratory, and policymakers at Centers for Disease Control and Prevention rely on the ontology for phenotype-driven gene discovery, variant interpretation, and translational pipelines used by companies including Illumina, Roche, Thermo Fisher Scientific, 23andMe, and Genentech.

History and Development

Initial efforts began as collaborations among academic groups at Harvard Medical School, University of Cambridge, University of Oxford, University of Freiburg, and University of California, San Francisco with funding and support from funders such as the Wellcome Trust, National Human Genome Research Institute, and European Research Council. Early implementations interfaced with resources curated by teams at OMIM, Gene Ontology Consortium, Swiss-Prot, RefSeq, and PubMed Central. Development milestones were achieved through workshops held at venues like Cold Spring Harbor Laboratory, European Molecular Biology Laboratory, Max Planck Institute, American Society of Human Genetics meetings, and collaborations with projects such as PhenomeCentral, Matchmaker Exchange, Global Alliance for Genomics and Health, and Human Variome Project.

Structure and Content

The ontology is organized as a hierarchical directed acyclic graph with terms annotated and cross-referenced to databases including OMIM, UniProt, Ensembl, NCBI, and HGNC. Each term is associated with metadata curated using standards promoted by organizations like World Wide Web Consortium, BioPortal, Open Biological and Biomedical Ontology Foundry, and International Organization for Standardization. The term set encompasses entries relevant to clinics at Seattle Children's Hospital, Toronto General Hospital, Karolinska University Hospital, Sheffield Children's Hospital, and Tokyo Metropolitan Children's Medical Center, and maps to coding systems maintained by ICD-10, SNOMED CT, LOINC, and RXNorm where appropriate. The ontology integrates phenotype annotations used in research by teams at Broad Institute, Sanger Institute, University of Washington, University of Pennsylvania, and Yale University.

Applications and Use Cases

Clinical genetics services at Great Ormond Street Hospital, Boston Children's Hospital, Texas Children's Hospital, and Sheba Medical Center use the ontology for differential diagnosis pipelines linked to variant interpretation frameworks from ACMG/AMP and reporting workflows at Mayo Clinic Laboratories and Quest Diagnostics. Research projects at Harvard Medical School, Stanford University School of Medicine, University of California, Los Angeles, and University of Michigan apply the ontology for phenotype-driven gene discovery, rare disease matchmaking with PhenomeCentral and Matchmaker Exchange, and large-scale phenotype mining in cohorts like UK Biobank and All of Us. Pharmaceutical and biotech companies including Pfizer, Novartis, Amgen, Regeneron, and Biogen incorporate the ontology into target identification, clinical trial stratification, and post-marketing safety surveillance in collaboration with regulators such as Food and Drug Administration and European Medicines Agency.

Integration and Interoperability

Interoperability efforts link the ontology to resources maintained by Ensembl, NCBI Gene, ClinVar, HGMD, dbSNP, and BioGRID, and enable crosswalks to medical coding systems used by Centers for Medicare & Medicaid Services, NHS England, Kaiser Permanente, and Veterans Health Administration. Technical integrations utilize standards and tools developed by GA4GH, HL7, FHIR, OWL, RDF, SPARQL, and platforms such as BioPortal and Ontobee. Collaborative data sharing occurs with registries and networks including Rare Disease International, EURORDIS, Orphanet, Global Alliance for Genomics and Health, and national biobanks like FinnGen and deCODE genetics.

Community, Curation, and Governance

A global community of clinicians, researchers, and curators from institutions like University College London, Imperial College London, McGill University, University of Melbourne, and National University of Singapore contributes to ongoing curation, updates, and quality control. Governance models draw on practices from organizations such as Gene Ontology Consortium, Open Biological and Biomedical Ontology Foundry, ELIXIR, Genoscope, and European Bioinformatics Institute with funding and oversight by funders like Wellcome Trust, National Institutes of Health, Horizon Europe, and philanthropic groups including Gates Foundation. Training and outreach occur via conferences hosted by American Society of Human Genetics, European Society of Human Genetics, Cold Spring Harbor Laboratory, and workshops supported by Global Alliance for Genomics and Health.

Category:Medical ontologies